$0.820000
0.00750.92%
Last update: 9:19 AM
15 minutes delayed
Comments
Loading...
BioLine Rx
BLRXNASDAQ
BioLine Rx (NASDAQ:BLRX) Stock, Earnings Estimates, EPS, And Revenue
BioLine Rx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 28
EPS Estimate
$-0.140
Quarterly Revenue Estimate
$3.9M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$11.7M
Analyze the earnings history of BioLine Rx using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BLRX | BioLine Rx | -$0.30 | -$0.14 | — | — | $0.00 | $3.93M | — | — | 08/28/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.10 | -$0.29 | -$0.01 | 96.55% | $0.00 | — | $6.86M | — | 05/28/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.08 | -$0.22 | -$0.15 | — | $0.00 | — | $4.80M | — | 03/26/2024 | Get Alert |
| BLRX | BioLine Rx | -$0.02 | -$0.21 | -$0.26 | -23.81% | $0.00 | — | $0.00 | — | 11/20/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.02 | — | -$0.30 | — | $0.00 | — | $0.00 | — | 08/30/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.10 | — | -$0.10 | — | $0.00 | — | $0.00 | — | 05/24/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.18 | -$0.14 | -$0.08 | 42.86% | $0.00 | — | $0.00 | — | 03/22/2023 | Get Alert |
| BLRX | BioLine Rx | -$0.01 | -$0.11 | -$0.15 | -36.36% | $0.00 | — | $0.00 | — | 11/15/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.15 | -$0.07 | -$0.15 | -114.29% | $0.00 | — | $0.00 | — | 08/16/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.02 | -$0.15 | -$0.10 | 33.33% | $0.00 | — | $0.00 | — | 05/11/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.60 | -$0.14 | -$0.18 | -28.57% | $0.00 | — | $0.00 | — | 03/16/2022 | Get Alert |
| BLRX | BioLine Rx | -$0.30 | -$0.16 | -$0.15 | 6.25% | $0.00 | — | $0.00 | — | 11/18/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.45 | -$0.15 | -$0.15 | 0.00% | $0.00 | — | $0.00 | — | 08/18/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.60 | -$0.15 | -$0.30 | -100.00% | $0.00 | — | $0.00 | — | 05/26/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.90 | -$0.27 | -$0.60 | -122.22% | $0.00 | — | $0.00 | — | 02/23/2021 | Get Alert |
| BLRX | BioLine Rx | -$0.45 | -$0.35 | -$0.30 | 14.29% | $0.00 | — | $0.00 | — | 11/23/2020 | Get Alert |
| BLRX | BioLine Rx | -$0.60 | -$0.73 | -$0.45 | 38.36% | $0.00 | — | $0.00 | — | 08/06/2020 | Get Alert |
| BLRX | BioLine Rx | -$0.75 | -$0.66 | -$0.60 | 9.09% | $0.00 | — | $0.00 | — | 05/20/2020 | Get Alert |
| BLRX | BioLine Rx | -$1.20 | -$0.66 | -$0.90 | -36.36% | $0.00 | — | $0.00 | — | 03/12/2020 | Get Alert |
| BLRX | BioLine Rx | -$0.90 | -$0.64 | -$0.45 | 29.69% | $0.00 | $100.00K | $0.00 | -100.00% | 11/11/2019 | Get Alert |
| BLRX | BioLine Rx | -$0.75 | -$0.63 | -$0.60 | 4.76% | $0.00 | $80.00K | $0.00 | -100.00% | 08/06/2019 | Get Alert |
BioLine Rx (BLRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-28 | $-0.01 | $-0.29 | 96.5 % |
| Sep 2023 | 2023-11-20 | $-0.26 | $-0.21 | -23.8 % |
| Dec 2022 | 2023-03-22 | $-0.08 | $-0.14 | 42.9 % |
| Sep 2022 | 2022-11-15 | $-0.15 | $-0.11 | -36.4 % |
BioLine Rx (BLRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2019 | 2019-11-11 | $0 | $100.00K | -100.0 % |
| Jun 2019 | 2019-08-06 | $0 | $80.00K | -100.0 % |
FAQ
When is BioLine Rx (NASDAQ:BLRX) reporting earnings?
BioLine Rx (BLRX) is scheduled to report earnings on August 28, 2024. The last reported earnings were for reported on May 28, 2024 for Q1.
What were the latest earnings per share (EPS) for BioLine Rx (NASDAQ:BLRX)?
The Actual EPS was $-0.01, which beat the estimate of $-0.29.
What were BioLine Rx’s (NASDAQ:BLRX) revenues?
The Actual Revenue was $6.9M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.